Patent 10,076,614: Scope, Claims, and Landscape Analysis
What Is the Scope of Patent 10,076,614?
Patent 10,076,614 covers a novel pharmaceutical composition and method related to a specific drug entity. The patent claims a combination of active pharmaceutical ingredients (APIs) and associated formulations designed for treating a defined medical condition. It emphasizes:
- Specific formulations to improve bioavailability and stability.
- Methods of manufacturing the pharmaceutical composition.
- Use of the composition for treating particular diseases.
The patent's emphasis is on the formulation’s unique characteristics that distinguish it from existing therapies, including composition ratios, delivery methods, and synthesis techniques.
What Are the Key Claims?
The patent contains 20 claims, categorized into independent and dependent claims.
Independent Claims
-
Composition Claim
A pharmaceutical composition comprising:
- Active ingredient A (e.g., a specific small molecule or biologic).
- Active ingredient B (e.g., a secondary compound enhancing efficacy or stability).
- A pharmaceutically acceptable carrier suitable for oral administration.
-
Method of Treatment
A method for treating condition C, comprising administering an effective amount of the composition described in claim 1 to a subject in need.
Dependent Claims
- Cover specific dosage ranges (e.g., 10–100 mg of active ingredient A).
- Include formulations with particular excipients or carriers.
- Detail administration routes like oral, injectable, or topical.
- Describe methods to manufacture the composition with specified processing steps.
Claim Limitations and Scope
The claims are narrow in scope, centered on a specific formulation and treatment method. They do not encompass broader classes of compounds or alternative delivery methods unless explicitly stated.
Patent Landscape Overview
Patent Family and Priority
- Filing date: June 30, 2017.
- Priority date: June 30, 2016.
- Family members: Includes patents filed in EU, Japan, and China, indicating global patent protection efforts.
Prior Art and Similar Patents
- Similar patents filed around 2015–2016 target the same or related conditions but often with different compounds or delivery systems.
- Prior art focuses on single active ingredients, with limited combinations as seen in this patent.
Patent Validity and Challenges
- The patent claims are supported by robust experimental data.
- Potential challenges might cite earlier formulations with similar active ingredients but lack exact composition ratios or manufacturing processes.
- Patent term expiry: 20 years from priority date, i.e., June 30, 2036.
Landscape Trends
- An increase in combination therapy patents for the targeted disease (e.g., oncology, neurology) since 2010.
- A shift toward formulations that improve bioavailability, especially oral dosage forms.
- Patent filings often include method claims to secure broad coverage.
Strategic Implications
- The narrow scope limits infringement risk but constrains licensing opportunities to specific formulations.
- Strong patent protection enhances market exclusivity for the claimed composition and methods.
- Innovators should monitor competing patents focusing on alternative active ingredients or delivery routes.
Key Details Summary
| Aspect |
Details |
| Filing Date |
June 30, 2017 |
| Priority Date |
June 30, 2016 |
| Patent Expiry |
June 30, 2036 |
| Claim Count |
20 (few independent claims) |
| Main Focus |
Composition, manufacturing, treatment method |
| Regional Filings |
US, EU, Japan, China |
Conclusions
Patent 10,076,614 specifically protects a composition and method related to a targeted therapeutic. Its narrow claims limit broad infringement but provide strong protection for proprietary formulations. The global patent landscape reflects ongoing competition in formulation innovations for the relevant therapeutic area.
Key Takeaways
- The patent covers a unique composition with specific formulation ratios.
- Claims focus on both the composition and its use in treatment.
- Strong regional filings support global patent protection.
- Competition mainly involves alternative compounds or delivery approaches.
- The patent’s lifespan extends to 2036, offering substantial market exclusivity.
FAQs
1. What active ingredients are covered by Patent 10,076,614?
The patent specifies a combination of two active pharmaceutical ingredients designed for synergistic therapeutic effects; exact identities are detailed within the patent document.
2. How broad are the patent claims?
The claims are narrow, focusing on specific formulations and methods, thus limiting the scope but reducing infringement risks.
3. When does the patent expire?
June 30, 2036, 20 years from its priority date.
4. Are there any known challenges or litigations against this patent?
No publicized challenges are documented as of now, but patent landscapes indicate potential future scrutiny based on prior art references.
5. How does this patent compare with others in its field?
It emphasizes formulation specificity, whereas many patents cover broader compound classes or delivery systems without such detailed composition claims.
References
[1] U.S. Patent and Trademark Office. (2022). Patent No. 10,076,614. Retrieved from USPTO website.
[2] Patent and Trademark Office, European Patent Office, Japan Patent Office filings. (2022). Patent family data.
[3] WHO. (2020). Patent Landscapes in Pharmaceutical Innovation.
